日本厚生劳动省批准贝罗司他胶囊用于遗传性血管性水肿的预防性治疗！

Selective human plasma kallikrein inhibitor is a new, oral, once-daily, powerful drug that has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) for sales and production approval for the prevention of angioedema (HAE) in adults and children over 12 years old. It is the first and only preventive HAE drug approved in Japan.

So, what is the effect of berosostat capsules on hereditary angioedema?

In the long-term open-label trial APeX-S, patients who completed 48 weeks of treatment (150 mg) had an average number of exacerbations per month of 0.8. In the pivotal Phase 3 clinical trial APeX-2, patients who completed 48 weeks of treatment (150 mg) reduced the number of HAE episodes from an average of 2.9 per month at baseline to 1.0 per month after 48 weeks of treatment. Berosostat capsules demonstrated good safety and tolerability in both trials.

So, where can I buy Berostat capsules in China?

At present, berosostat capsules are on the market in the United States, but this drug is not yet available in China. Patients cannot buy berosostat capsules in domestic hospital pharmacies. Patients in need can go abroad to purchase, or obtain them through domestic professional overseas medical service agencies such as Medical Companion Travel. Direct mail from pharmaceutical companies makes purchasing medicines convenient and fast, and it can guarantee that the medicines are genuine. However, berosostat capsules are affected by exchange rate fluctuations, and the price of the drug is not fixed. It is recommended to consult the medical companion and passenger service staff for the specific costs and procedures required to purchase this product.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: